Activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome and the subsequent release of IL-1ß and IL-18 is implicated in the pathogenesis of chronic inflammatory liver diseases such as ASH and NAFLD [100]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.